DOCS (Doximity) Stock Based Compensation: $121.6 Mil (TTM As of Mar. 2026)


DOCS Doximity Inc DOCS
82 GF Score
Price $20.88
GF Value $49.18
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Doximity Stock Based Compensation?

Doximity DOCS +5.19% 82 Stock Based Compensation is $121.6 Mil as of Mar. 2026. GuruFocus rates DOCS with a GF Score™ of 82/100 and a GF Value™ of $49.18 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Doximity's Stock Based Compensation for the three months ended in Mar. 2026 was $36.7 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was $121.6 Mil.

Doximity Stock Based Compensation Related Terms

Doximity Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Doximity's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Doximity Stock Based Compensation Chart

Doximity Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Stock Based Compensation
Get a 7-Day Free Trial 31.44 47.83 51.08 72.39 121.63

Doximity Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.06 21.87 29.47 33.55 36.74
DOCS
82GF Score
Doximity Inc DOCS
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Doximity Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $121.6 Mil.

What does a Stock Based Compensation of $121.6 Mil mean?
Doximity (DOCS) has a Stock Based Compensation of $121.6 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Doximity and its competitors.
Is Doximity's Stock Based Compensation too high?
Doximity's current Stock Based Compensation is $121.6 Mil. Overall, Doximity has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Doximity's Stock Based Compensation compare to WAY and TXG?
Doximity's Stock Based Compensation of $121.6 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Doximity and its competitors. Doximity's current Stock Based Compensation is $121.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Doximity stock overvalued right now?
Based on GuruFocus' analysis, Doximity (DOCS) is currently considered Significantly Undervalued. The stock's GF Value™ is $49.18, compared to a current price of $20.88 — trading 57.5% below its estimated fair value. The current Stock Based Compensation is $121.6 Mil. Doximity's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Doximity (DOCS), the current Stock Based Compensation is $121.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Doximity (DOCS) Overvalued in 2026?

Based on GuruFocus' analysis, Doximity stock appears to be undervalued. The current stock price of $20.88 is trading 57.5% below its estimated GF Value™ of $49.18. GuruFocus considers Doximity to be Significantly Undervalued.

Key valuation signals for DOCS:

  • Stock Based Compensation: $121.6 Mil
  • GF Value™: $49.18 vs. price of $20.88 (57.5% below fair value)
  • GF Score™: 82/100 with 2 warning signs

No single metric tells the full story. See the DOCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Doximity Business Description

Other Exchanges D2OC34:Brazil
Address 500 3rd Street, Suite 510, San Francisco, CA, USA, 94107
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
82GF Score

Get the complete analysis for DOCS

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.88
Price
$49.18
GF Value